Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923
Gespeichert in:
| Veröffentlicht in: | Clinical microbiology and infection 2024-03, Vol.30 (3), p.409-413 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 413 |
|---|---|
| container_issue | 3 |
| container_start_page | 409 |
| container_title | Clinical microbiology and infection |
| container_volume | 30 |
| creator | Barda, Noam Lustig, Yaniv Indenbaum, Victoria Zibly, Daniel Joseph, Gili Asraf, Keren Weiss-Ottolenghi, Yael Amit, Sharon Kliker, Limor Abu-Kadar, Bian Ben-Ami, Eytan Canetti, Michal Koren, Ravit Katz-Likvornik, Shiri Halpern, Osnat Mendelson, Ella Doolman, Ram Harats, Dror Kreiss, Yitshak Mandelboim, Michal Regev-Yochay, Gili |
| description | |
| doi_str_mv | 10.1016/j.cmi.2023.12.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11021213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X23006237</els_id><sourcerecordid>2905524975</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2495-9a00b7a36e8f8309d0ac56dafeff78ad8cca2f36595113cbd783f021be6eb5203</originalsourceid><addsrcrecordid>eNp9kd9qFDEUxgdRbK0-gDeSyy04Y06yM5PohbRL1YVqbyoIIiGTP22WmWTNzKy0V_sO3ioIvomPsk9ilq1Fb7xKyPnO75x8X5Y9BlwAhurZolCdKwgmtABSYCjvZPswrXiOKw530x04y-sp_bCXPej7BcZJSaf3sz3KgLCa4f3s5yzE6C6M12OHhoA262_zrht9SE9OueEKBYvOOqdi8Oj4qIBcarkcjEbH786hIg1BK6mU86Z_jqL0OnTuOlWH6GT7FNG8C364RDa0bfiSj8vN-jv6OGud__Xj7RbauNCiubdGDZ8Q4WhSH6LJ9keHiAPbrL9yQh9m96xse_Po5jzI3r86OZ-9yU_PXs9nR6e5IlNe5lxi3NSSVoZZRjHXWKqy0tIaa2smNVNKEkurkpcAVDW6ZtRiAo2pTFMSTA-ylzvucmw6o5XxQ5StWEbXyXglgnTi34p3l-IirARAwhCgiTC5IcTweTT9IDrXK9O20psw9oJwXJZp2bpMUthJkwl9H429nQNYbNMVC5HSFVsvBBCR0k09T_5e8LbjT5xJ8GInMMmmlTNR9MoZr4x2MTksdHD_wf8GsmO3sQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2905524975</pqid></control><display><type>article</type><title>Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923</title><source>Alma/SFX Local Collection</source><creator>Barda, Noam ; Lustig, Yaniv ; Indenbaum, Victoria ; Zibly, Daniel ; Joseph, Gili ; Asraf, Keren ; Weiss-Ottolenghi, Yael ; Amit, Sharon ; Kliker, Limor ; Abu-Kadar, Bian ; Ben-Ami, Eytan ; Canetti, Michal ; Koren, Ravit ; Katz-Likvornik, Shiri ; Halpern, Osnat ; Mendelson, Ella ; Doolman, Ram ; Harats, Dror ; Kreiss, Yitshak ; Mandelboim, Michal ; Regev-Yochay, Gili</creator><creatorcontrib>Barda, Noam ; Lustig, Yaniv ; Indenbaum, Victoria ; Zibly, Daniel ; Joseph, Gili ; Asraf, Keren ; Weiss-Ottolenghi, Yael ; Amit, Sharon ; Kliker, Limor ; Abu-Kadar, Bian ; Ben-Ami, Eytan ; Canetti, Michal ; Koren, Ravit ; Katz-Likvornik, Shiri ; Halpern, Osnat ; Mendelson, Ella ; Doolman, Ram ; Harats, Dror ; Kreiss, Yitshak ; Mandelboim, Michal ; Regev-Yochay, Gili</creatorcontrib><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1016/j.cmi.2023.12.015</identifier><identifier>PMID: 38128780</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Clinical microbiology and infection, 2024-03, Vol.30 (3), p.409-413</ispartof><rights>2023</rights><rights>2023 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38128780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barda, Noam</creatorcontrib><creatorcontrib>Lustig, Yaniv</creatorcontrib><creatorcontrib>Indenbaum, Victoria</creatorcontrib><creatorcontrib>Zibly, Daniel</creatorcontrib><creatorcontrib>Joseph, Gili</creatorcontrib><creatorcontrib>Asraf, Keren</creatorcontrib><creatorcontrib>Weiss-Ottolenghi, Yael</creatorcontrib><creatorcontrib>Amit, Sharon</creatorcontrib><creatorcontrib>Kliker, Limor</creatorcontrib><creatorcontrib>Abu-Kadar, Bian</creatorcontrib><creatorcontrib>Ben-Ami, Eytan</creatorcontrib><creatorcontrib>Canetti, Michal</creatorcontrib><creatorcontrib>Koren, Ravit</creatorcontrib><creatorcontrib>Katz-Likvornik, Shiri</creatorcontrib><creatorcontrib>Halpern, Osnat</creatorcontrib><creatorcontrib>Mendelson, Ella</creatorcontrib><creatorcontrib>Doolman, Ram</creatorcontrib><creatorcontrib>Harats, Dror</creatorcontrib><creatorcontrib>Kreiss, Yitshak</creatorcontrib><creatorcontrib>Mandelboim, Michal</creatorcontrib><creatorcontrib>Regev-Yochay, Gili</creatorcontrib><title>Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kd9qFDEUxgdRbK0-gDeSyy04Y06yM5PohbRL1YVqbyoIIiGTP22WmWTNzKy0V_sO3ioIvomPsk9ilq1Fb7xKyPnO75x8X5Y9BlwAhurZolCdKwgmtABSYCjvZPswrXiOKw530x04y-sp_bCXPej7BcZJSaf3sz3KgLCa4f3s5yzE6C6M12OHhoA262_zrht9SE9OueEKBYvOOqdi8Oj4qIBcarkcjEbH786hIg1BK6mU86Z_jqL0OnTuOlWH6GT7FNG8C364RDa0bfiSj8vN-jv6OGud__Xj7RbauNCiubdGDZ8Q4WhSH6LJ9keHiAPbrL9yQh9m96xse_Po5jzI3r86OZ-9yU_PXs9nR6e5IlNe5lxi3NSSVoZZRjHXWKqy0tIaa2smNVNKEkurkpcAVDW6ZtRiAo2pTFMSTA-ylzvucmw6o5XxQ5StWEbXyXglgnTi34p3l-IirARAwhCgiTC5IcTweTT9IDrXK9O20psw9oJwXJZp2bpMUthJkwl9H429nQNYbNMVC5HSFVsvBBCR0k09T_5e8LbjT5xJ8GInMMmmlTNR9MoZr4x2MTksdHD_wf8GsmO3sQ</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Barda, Noam</creator><creator>Lustig, Yaniv</creator><creator>Indenbaum, Victoria</creator><creator>Zibly, Daniel</creator><creator>Joseph, Gili</creator><creator>Asraf, Keren</creator><creator>Weiss-Ottolenghi, Yael</creator><creator>Amit, Sharon</creator><creator>Kliker, Limor</creator><creator>Abu-Kadar, Bian</creator><creator>Ben-Ami, Eytan</creator><creator>Canetti, Michal</creator><creator>Koren, Ravit</creator><creator>Katz-Likvornik, Shiri</creator><creator>Halpern, Osnat</creator><creator>Mendelson, Ella</creator><creator>Doolman, Ram</creator><creator>Harats, Dror</creator><creator>Kreiss, Yitshak</creator><creator>Mandelboim, Michal</creator><creator>Regev-Yochay, Gili</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202403</creationdate><title>Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923</title><author>Barda, Noam ; Lustig, Yaniv ; Indenbaum, Victoria ; Zibly, Daniel ; Joseph, Gili ; Asraf, Keren ; Weiss-Ottolenghi, Yael ; Amit, Sharon ; Kliker, Limor ; Abu-Kadar, Bian ; Ben-Ami, Eytan ; Canetti, Michal ; Koren, Ravit ; Katz-Likvornik, Shiri ; Halpern, Osnat ; Mendelson, Ella ; Doolman, Ram ; Harats, Dror ; Kreiss, Yitshak ; Mandelboim, Michal ; Regev-Yochay, Gili</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2495-9a00b7a36e8f8309d0ac56dafeff78ad8cca2f36595113cbd783f021be6eb5203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barda, Noam</creatorcontrib><creatorcontrib>Lustig, Yaniv</creatorcontrib><creatorcontrib>Indenbaum, Victoria</creatorcontrib><creatorcontrib>Zibly, Daniel</creatorcontrib><creatorcontrib>Joseph, Gili</creatorcontrib><creatorcontrib>Asraf, Keren</creatorcontrib><creatorcontrib>Weiss-Ottolenghi, Yael</creatorcontrib><creatorcontrib>Amit, Sharon</creatorcontrib><creatorcontrib>Kliker, Limor</creatorcontrib><creatorcontrib>Abu-Kadar, Bian</creatorcontrib><creatorcontrib>Ben-Ami, Eytan</creatorcontrib><creatorcontrib>Canetti, Michal</creatorcontrib><creatorcontrib>Koren, Ravit</creatorcontrib><creatorcontrib>Katz-Likvornik, Shiri</creatorcontrib><creatorcontrib>Halpern, Osnat</creatorcontrib><creatorcontrib>Mendelson, Ella</creatorcontrib><creatorcontrib>Doolman, Ram</creatorcontrib><creatorcontrib>Harats, Dror</creatorcontrib><creatorcontrib>Kreiss, Yitshak</creatorcontrib><creatorcontrib>Mandelboim, Michal</creatorcontrib><creatorcontrib>Regev-Yochay, Gili</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barda, Noam</au><au>Lustig, Yaniv</au><au>Indenbaum, Victoria</au><au>Zibly, Daniel</au><au>Joseph, Gili</au><au>Asraf, Keren</au><au>Weiss-Ottolenghi, Yael</au><au>Amit, Sharon</au><au>Kliker, Limor</au><au>Abu-Kadar, Bian</au><au>Ben-Ami, Eytan</au><au>Canetti, Michal</au><au>Koren, Ravit</au><au>Katz-Likvornik, Shiri</au><au>Halpern, Osnat</au><au>Mendelson, Ella</au><au>Doolman, Ram</au><au>Harats, Dror</au><au>Kreiss, Yitshak</au><au>Mandelboim, Michal</au><au>Regev-Yochay, Gili</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2024-03</date><risdate>2024</risdate><volume>30</volume><issue>3</issue><spage>409</spage><epage>413</epage><pages>409-413</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38128780</pmid><doi>10.1016/j.cmi.2023.12.015</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1198-743X |
| ispartof | Clinical microbiology and infection, 2024-03, Vol.30 (3), p.409-413 |
| issn | 1198-743X 1469-0691 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11021213 |
| source | Alma/SFX Local Collection |
| title | Corrigendum to “Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up” [Clin Microbiol Infect] 29 (7) (2023) 918–923 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A59%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%9CImmunogenicity%20of%20Omicron%20BA.1-adapted%20BNT162b2%20vaccines:%20randomized%20trial,%203-month%20follow-up%E2%80%9D%20%5BClin%C2%A0Microbiol%20Infect%5D%2029%20(7)%20(2023)%20918%E2%80%93923&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Barda,%20Noam&rft.date=2024-03&rft.volume=30&rft.issue=3&rft.spage=409&rft.epage=413&rft.pages=409-413&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1016/j.cmi.2023.12.015&rft_dat=%3Cproquest_pubme%3E2905524975%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2905524975&rft_id=info:pmid/38128780&rft_els_id=S1198743X23006237&rfr_iscdi=true |